Recombinant Human herpesvirus 1 Envelope glycoprotein E (gE)

What is glycoprotein E (gE) in Herpes Simplex Virus Type 1?

Glycoprotein E is an essential envelope protein embedded in the HSV-1 viral membrane that extends into both the extracellular environment and cytoplasmic space. As a viral surface protein, gE plays multiple roles in the viral life cycle, particularly in cell-to-cell spread and virus-induced cell fusion . The protein undergoes extensive post-translational modifications, including N-glycosylation, O-glycosylation, and sialylation, which are critical for its proper function. gE belongs to the broader family of herpesvirus envelope glycoproteins that mediate crucial interactions between the virus and host cells during infection.

What are the primary functions of HSV-1 gE?

HSV-1 glycoprotein E serves several essential functions during viral infection:

• Cell-to-cell spread: gE plays a key role in facilitating direct virus transmission between adjacent cells, which allows the virus to evade neutralizing antibodies in the extracellular environment .

• Virus-induced cell fusion: gE contributes significantly to the fusion of infected cells with neighboring uninfected cells, forming multinucleated syncytia that facilitate viral spread .

• Axonal localization: Research has shown that gE is required for the proper localization of viral capsid, tegument, and membrane glycoproteins in axons, which is crucial for neuronal infection .

• Targeting to epithelial cell junctions: gE, often in complex with glycoprotein I (gI), sorts nascent virions to epithelial cell junctions, promoting efficient viral spread in epithelial tissues .

• Retrograde spread: gE mediates retrograde spread of the virus from epithelial cells to neurites, which is important for establishing latent infection in sensory ganglia .

What proteins interact with gE during the viral life cycle?

Glycoprotein E participates in a network of protein-protein interactions that are critical for its function:

Research by Maringer et al. has demonstrated that tegument proteins UL11, UL16, and UL21 come together with very high efficiency to form a complex with gE in transfected cells in a regulated and coordinated manner . Notably, the interaction of UL16 with membrane proteins (UL11 and gE), which is inefficient in pairwise transfections, becomes efficient when other binding partners are present, suggesting a coordinated assembly process .

How do tegument proteins UL11, UL16, and UL21 modulate gE function?

The tegument proteins UL11, UL16, and UL21 collectively modulate gE function through a sophisticated interaction network:

• Complex formation: These three tegument proteins assemble on the cytoplasmic tail of gE to form a highly efficient complex in vivo . This assembly occurs in a coordinated manner, with the presence of certain components enhancing the interaction efficiency of others.

• Processing regulation: Studies of viral mutants have revealed that each of these tegument proteins is critical for the proper processing of gE . In the absence of UL11, UL16, or UL21, gE processing is compromised, affecting its functional capacity.

• Transport facilitation: The tegument protein complex plays an essential role in the transport of gE within infected cells, ensuring that it reaches the appropriate cellular compartments for viral assembly and budding .

• Biological activity: The function of gE in processes such as cell-to-cell spread and virus-induced cell fusion requires the cooperation of UL11, UL16, and UL21 . Without these tegument proteins, gE's biological activity is significantly reduced.

The significance of these interactions was revealed through studies of viral mutants, which demonstrated that each of these tegument proteins is critical for the processing, transport, and biological activity of gE . This finding has important implications for understanding HSV assembly and budding mechanisms.

What experimental approaches are most effective for studying gE-protein interactions?

Several experimental approaches have proven effective for investigating gE-protein interactions:

• Transfection studies with co-immunoprecipitation: This approach involves co-transfecting cells with plasmids encoding gE and its potential interaction partners, followed by co-immunoprecipitation to detect protein complexes. This method was successfully used to demonstrate the complex formation between gE, UL11, UL16, and UL21, revealing that these proteins come together with high efficiency to form a complex in transfected cells .

• Viral mutagenesis: Generating HSV-1 mutants with deletions or modifications in gE or its interaction partners can reveal the functional significance of specific interactions. Studies with viral mutants have confirmed that tegument proteins UL11, UL16, and UL21 are critical for the proper functioning of gE .

• Biochemical analysis of protein complexes: Techniques such as size exclusion chromatography, chemical crosslinking, and mass spectrometry can be used to characterize the composition and stoichiometry of gE-containing protein complexes.

• Fluorescence microscopy: Using fluorescently tagged versions of gE and its interaction partners can enable visualization of protein localization and co-localization in living cells.

• Structural biology approaches: X-ray crystallography and cryo-electron microscopy can provide detailed information about the three-dimensional structure of gE alone or in complex with its interaction partners.

When designing experiments to study gE-protein interactions, it is important to consider the coordinated nature of these interactions, as the efficiency of certain interactions (e.g., UL16 with gE) significantly increases when other binding partners are present .

How can recombinant gE be engineered for targeted viral tropism?

Engineering recombinant gE for targeted viral tropism requires strategic modifications while preserving essential functions:

• Domain identification: First, researchers must identify which domains of gE can be modified without disrupting its core functions in viral assembly and spread. Understanding the structure-function relationship is critical for successful engineering.

• Targeting strategies: Several approaches can be employed:

  a. Domain replacement: Critical domains of gE can be replaced with ligands that bind to specific cell surface receptors, redirecting viral tropism to cells expressing those receptors.

  b. Addition of targeting motifs: Ligands or antibody fragments can be fused to gE to create chimeric proteins that retain gE function while gaining new receptor specificity.

• Complementary modifications: For optimal targeting, modifications to gE should be accompanied by alterations to other envelope glycoproteins involved in cell attachment and entry.

Although the search results don't provide specific examples of engineering gE for targeted tropism, they describe a related approach with glycoprotein C (gC). Researchers created a recombinant HSV-1 in which the heparan sulfate binding domain of gC was replaced with erythropoietin (EPO), resulting in a virus that could bind to cells expressing the EPO receptor . This recombinant virus (KgBpK−gCEPO2) was specifically retained on a soluble EPO receptor column, was neutralized by soluble EPO receptor, and stimulated proliferation of EPO growth-dependent cells .

A similar strategy could potentially be applied to gE, though researchers must consider that modifications may affect protein processing, transport, and incorporation into the viral envelope.

What are the methodological challenges in expressing functional recombinant HSV-1 gE?

Expressing functional recombinant HSV-1 gE presents several methodological challenges:

• Preserving protein folding and conformation: Modifications to gE may disrupt its proper folding, leading to non-functional protein. Research has shown that modifications of HSV glycoproteins can result in defective recombinant molecule processing and/or intracellular trafficking, consequently leading to failure in incorporating the modified protein into virus envelopes .

• Post-translational modification requirements: gE undergoes complex post-translational modifications that are essential for its function. The expression system must be capable of performing these modifications correctly, typically necessitating mammalian cell-based expression systems.

• Maintaining critical protein-protein interactions: As demonstrated by Maringer et al., gE functions through interactions with multiple partners, including tegument proteins UL11, UL16, and UL21 . Recombinant versions must preserve these interaction capabilities.

• Ensuring proper protein transport: Changes to gE may affect its transport to the cell surface and incorporation into virions. When engineering recombinant gE, researchers must verify that the modified protein is properly transported to the cell surface and can be incorporated into the viral envelope.

• Expression level optimization: Over-expression or under-expression of recombinant gE can lead to artifacts or insufficient protein for analysis. Expression levels should be carefully controlled, potentially using inducible expression systems.

• Selection of appropriate cellular context: The functionality of recombinant gE may depend on the cellular context in which it is expressed, particularly given the importance of cell-type specific factors in gE processing and function.

How does gE contribute to neuronal infection and retrograde transport of HSV-1?

Glycoprotein E plays critical roles in neuronal infection and retrograde transport of HSV-1:

• Axonal localization: Research has demonstrated that gE is required for the axonal localization of viral capsid, tegument, and membrane glycoproteins, which is essential for neuronal infection . Without gE, viral components fail to properly localize within neuronal axons, significantly impairing neuronal infection.

• Retrograde transport: gE mediates retrograde spread of HSV-1 from epithelial cells to neurites, facilitating the establishment of infection in neurons following initial infection at epithelial surfaces . This function is crucial for the virus's ability to reach and establish latency in sensory ganglia.

• Neuron-specific functions: The role of gE in neurons appears to be distinct from its function in epithelial cells, reflecting specializations for neuronal infection and transport. Studies have shown that HSV-2 gE is required for targeting viral proteins from the neuron cell body into axons, indicating a crucial role in axonal transport .

• Interaction with neuronal transport machinery: Although not explicitly detailed in the search results, gE likely interacts with components of the neuronal transport machinery to facilitate movement of viral particles along axons.

These neuronal-specific functions of gE highlight the sophisticated adaptations of HSV-1 for neuroinvasion and establish gE as a potential target for interventions aimed at preventing neurological complications of HSV infection.